Canada markets open in 5 hours

BioSyent Inc. (BIOYF)

Other OTC - Other OTC Delayed Price. Currency in USD
Add to watchlist
6.28+0.02 (+0.38%)
At close: 02:25PM EDT
Show:
Balance Sheet
Cash Flow
Annual

Income Statement

All numbers in thousands
Breakdown
ttm
2023-12-31
2022-12-31
2021-12-31
2020-12-31
Total Revenue
31,590
31,590
27,925
28,618
22,332
Cost of Revenue
5,992
5,992
5,067
5,980
4,908
Gross Profit
25,598
25,598
22,858
22,638
17,424
Operating Expenses
Research Development
83.271
83.271
121.025
160.675
222.361
Selling General and Administrative
17,267
17,267
15,232
13,657
11,463
Total Operating Expenses
18,064
18,064
15,951
14,390
12,298
Operating Income or Loss
7,534
7,534
6,907
8,248
5,126
Interest Expense
68.411
68.411
77.142
85.246
92.942
Total Other Income/Expenses Net
-63.114
-63.114
75.159
78.99
-58.829
Income Before Tax
8,534
8,534
7,431
8,378
5,237
Income Tax Expense
2,074
2,074
1,972
2,097
1,442
Income from Continuing Operations
6,460
6,460
5,458
6,282
3,795
Net Income
6,460
6,460
5,458
6,282
3,795
Net Income available to common shareholders
6,460
6,460
5,458
6,282
3,795
Basic EPS
0.52
-
0.44
0.49
0.29
Diluted EPS
0.51
-
0.43
0.49
0.29
Basic Average Shares
12,028
-
12,303
12,689
12,977
Diluted Average Shares
12,255
-
12,541
12,871
13,094